000			02111 a2200601 4500
005			20250516073439.0
264		0	_c20121217
008			201212s 0 0 eng d
022			_a1478-6362
024	7		_a10.1186/ar3685 _2doi
040			_aNLM _beng _cNLM
100	1		_aFleishaker, Dona L
245	0	0	_aMaraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial. _h[electronic resource]
260			_bArthritis research & therapy _cJan 2012
300			_aR11 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntirheumatic Agents _xadverse effects
650	0	4	_aArea Under Curve
650	0	4	_aArthritis, Rheumatoid _xdrug therapy
650	0	4	_aCCR5 Receptor Antagonists
650	0	4	_aConstipation _xchemically induced
650	0	4	_aCyclohexanes _xadverse effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMaraviroc
650	0	4	_aMetabolic Clearance Rate
650	0	4	_aMethotrexate _xadverse effects
650	0	4	_aMiddle Aged
650	0	4	_aNausea _xchemically induced
650	0	4	_aTreatment Failure
650	0	4	_aTriazoles _xadverse effects
650	0	4	_aYoung Adult
700	1		_aGarcia Meijide, Juan A
700	1		_aPetrov, Andriy
700	1		_aKohen, Michael David
700	1		_aWang, Xin
700	1		_aMenon, Sujatha
700	1		_aStock, Thomas C
700	1		_aMebus, Charles A
700	1		_aGoodrich, James M
700	1		_aMayer, Howard B
700	1		_aZeiher, Bernhardt G
773	0		_tArthritis research & therapy _gvol. 14 _gno. 1 _gp. R11
856	4	0	_uhttps://doi.org/10.1186/ar3685 _zAvailable from publisher's website
999			_c21466986 _d21466986